Ropharma shareholders Tuesday approved the company’s 2014 budget of revenue and expenditure.
In 2013, the company’s sales rose slightly to RON411.2 million and its profit increased nearly 3% to RON7.2 million.
Ropharma has two production units, in Targu Mures and Chisinau, where it makes nutritional supplements and medicines. The distribution company has five warehouses and 1,200 client pharmacies, besides its own drugstore network of 127 units.
Ropharma plans to invest around RON7.2 million in 2014, half of which in obtaining new pharmacy licenses pharmacies. The company also plans to launch 13 new products.
Ropharma ranks eighth among local pharmaceutical wholesalers, with a 3.3% market share, and fifth on the retail segment. The company employs over 900 people.
According to the latest reports to the stock exchange, businessman Mihai Miron indirectly owns 31.65% of Ropharma. He controls 14.12% via Rimia Investments and 17.53% via ADD Pharmaceuticals. U.S.-registered Arrow Pharmaceuticals owns 31.29% in Ropharma.
Other shareholders include private pension funds AZT Viitorul Tau – Allianz, with 5.87%, and private pension fund ING with 4.99%.